Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer

References

Page 1

	Year	Citations
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells Weihong Liu, Amy Putnam, Xuyu Zhou, The Journal of Experimental Medicine T-regulatory CellImmune RegulationImmunologyRegulatory T CellsCd4 T Cell Responses	2006	2.6K
CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells Pushpa Pandiyan, Lixin Zheng, Satoru Ishihara, Nature Immunology Immune Cell DevelopmentT-regulatory CellImmune RegulationImmunologyCell Death	2007	1.2K
Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4 <sup>−</sup> NK1.1 <sup>−</sup> NKT cell population Jonathan M. Coquet, Sumone Chakravarti, Konstantinos Kyparissoudis, Proceedings of the National Academy of Sciences Lymphocyte DevelopmentT-regulatory CellImmunologyImmune RegulationPathology	2008	451
Sublingual immunotherapy induces IL-10–producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation Barbara Bohle, Tamar Kinaciyan, Marianne Gerstmayr, Journal of Allergy and Clinical Immunology InflammationAllergyImmune DeviationAllergen-specific T-cell ToleranceImmune Cell Development	2007	411
Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin Laura Strauss, Theresa L. Whiteside, Ashley Knights, The Journal of Immunology	2007	330
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Tetsu Kawano, Toshinori Nakayama, Noriaki Kamada, PubMed Cancer ResearchRadiation OncologyCell TherapyCancer ImmunosurveillanceImmunology	1999	260
Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Takeshi Azuma, Tsuyoshi Takahashi, Atsushi Kunisato, PubMed Adaptive Immune SystemT-regulatory CellImmunologyImmune RegulationRegulatory T Cells	2003	225
Sublingual vaccination with influenza virus protects mice against lethal viral infection Joo-Hye Song, Huan Huu Nguyen, Nicolas Çuburu, Proceedings of the National Academy of Sciences Inactivated Influenza VirusImmunologyMucosal Antibody ResponsesFlu VaccinationImmunotherapy	2008	201
Combination therapy of <i>in vitro</i>‐expanded natural killer T cells and α‐galactosylceramide‐pulsed antigen‐presenting cells in patients with recurrent head and neck carcinoma Naoki Kunii, S. Horiguchi, Shinichiro Motohashi, Cancer Science Cell TherapyImmunologyImmunoeditingPathologyMetronomic Chemotherapy	2009	181
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer Tetsuro Uchida, S. Horiguchi, Yuriko Tanaka, Cancer Immunology Immunotherapy Radiation OncologyCancer ImmunosurveillanceNasal SubmucosaMedicineImmunology	2007	158

Page 1